Company: INGN
Filing Date: 2025-05-19
Form Type: 8-K
Source: 0000950170-25-074437
Chunk: 1

Company: Inogen Inc
Filing Date: 2025-05-19
Form: 8-K
Item: Item 5.07
Chunk 1
---
Item 5.07 Submission of Matters to a Vote of Security Holders.

A total of 26,887,242 shares of the Company’s Common Stock were entitled to vote as of March 17, 2025, the record date for the Annual Meeting. 20,937,688 shares were represented at the Annual Meeting, either by proxy or by attending the meeting, constituting approximately 77.87% of the outstanding shares of Common Stock. The matters voted on at the Annual Meeting and the votes cast with respect to each such matter are set forth below:

1.

Election of Class II Directors.

The following nominees were elected to serve as Class II directors, to hold office until the Company’s 2028 annual meeting of stockholders or until his or her respective successor has been duly elected and qualified:

  Nominee                 Votes For      Votes Withheld      Broker Non-Votes  
 ───────────────────────────────────────────────────────────────────────────────
  Kevin King             12,829,383           5,575,022             2,533,283  
  Mary Kay Ladone        12,833,858           5,570,547             2,533,283  
  Kevin R. M. Smith      13,033,743           5,370,662             2,533,283  

2.

Ratification of Appointment of Independent Registered Public Accounting Firm.

The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025 was ratified based on the following results of voting:

   Votes For      Votes Against      Abstentions      Broker Non-Votes  
 ────────────────────────────────────────────────────────────────────────
  20,860,575             71,500            5,613      —                 

3.

Advisory Vote on Executive Compensation.

On an advisory, non-binding basis, the Company’s stockholders approved the named executive officers’ compensation as disclosed in the proxy statement. The votes regarding the proposal were as follows:

   Votes For      Votes Against      Abstentions      Broker Non-Votes  
 ────────────────────────────────────────────────────────────────────────
  16,712,886          1,637,377           54,142             2,533,283  

4.

Approval of the Amended and Restated 2023 Equity Incentive Plan.

The Company’s stockholders approved the